Objective We hypothesized that PWE have an increased risk to acquire COVID-19. This was
a historical cohort study to determine COVID-19 incidence, severity, mortality and risk factors …

Objective A multitude of observational studies have underscored a substantial comorbidity
between COVID-19 and epilepsy. This study was aimed at establishing a conclusive causal …

Objective People with epilepsy (PWE) may be at an increased risk of severe COVID‐19. It is
important to characterize this risk to inform PWE and for future health and care planning. We …

Objective To examine whether epilepsy-related deaths increased during the COVID-19
pandemic and if the proportion with COVID-19 listed as the underlying cause is different …

Background Scientific data regarding the prevalence of COVID-19 neurological
manifestations and prognosis in Latin America countries is still lacking. Therefore, the study …

Objective This study was undertaken to characterize changes in health care utilization and
mortality for people with epilepsy (PWE) during the COVID‐19 pandemic. Methods We …

Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A
Retrospective Cohort Study Taquet M, Devinsky O, Cross JH, Harrison PJ, Sen A …

Background Coronavirus disease 2019 (COVID-19) infection has been associated with
severe neurological consequences, including stroke or seizures, and less severe …

Objective To assess asymptomatic rates and severity of SARS‐CoV‐2 infection in people
with epilepsy and their healthcare workers in a long‐term care facility which had …

Background: Premature mortality is a significant part of the epilepsy burden and may vary
across populations, especially between high-income and lower-and middle-income …